Lantheus
Company Snapshot
Company Overview
Lantheus Holdings, Inc., is a leading radiopharmaceutical company. It classifies its products into three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. The Radiopharmaceutical Oncology segment includes diagnostics and therapeutics, with a focus on prostate cancer. The Precision Diagnostic segment includes diagnostics with a focus on cardiology. The Strategic Partnerships focus on enabling personalized medicine using biomarkers, digital solutions and pharma solutions platforms.
Lantheus produces and markets its products throughout the U.S., selling primarily to hospitals, independent diagnostic testing facilities, and radio pharmacies. Lantheus sells its products outside the U.S. through direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Lantheus In News
Company's Business Segments
- Radiopharmaceutical Oncology : This segment includes PYLARIFY, Other radiopharmaceutical oncology.
- Precision Diagnostics : This segment includes DEFINITY, TechneLite, Other precision diagnostics.
Applications/End User Industries
- Healthcare
- Pharmaceuticals
- Radiopharmaceuticals
- Oncology
- Diagnostics
- Precision Diagnostics
